Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer (Q79409152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Donald C McMillan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Sara Ramsey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Gavin W A Lamb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Michael Aitchison

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

205-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Metastatic renal carcinoma comprehensive prognostic system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

A systematic review of physicians' survival predictions in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22400

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22400

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNCR.22400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17149754%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference